Capital Flow Monitor · Sponsors · CIK 2092364
Blue Marlin Therapeutics, Inc.
200 GARRETT STREET, CHARLOTTESVILLE, VA, 22902 · 434-980-8104
Biotechnology · Limited Liability Company· inc. DELAWARE true 2025
Fit score
—
Offering
—
Sold
$100K
% sold
—
Investors
2
Min investment
$1
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-21 | D ·current | 506(b) | — | $100K | — | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Sean Stalfort — Executive Officer, Charlottesville, VA
2 other raises
- CURADEL SURGICAL INNOVATIONS, INC. $49.8M of $57.5M · 86.7%
- Verrica Pharmaceuticals Inc. $50.0M of $50.0M · 100.0%
- Paul Manning — Executive Officer, Charlottesville, VA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.